8-KThe WireStrategic
Material Agreement · Equity Issuance
Filed Sep 25, 2023 · 2y ago · Accession 0000950170-23-049683
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- 8-K
- Filing date
- Sep 25, 2023
- Report date
- Sep 25, 2023
- Document
- bbio-20230925.htm
- Size
- 780 KB